Literature DB >> 9508327

Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma.

H J Lin1, L Pedneault, F B Hollinger.   

Abstract

Three kits (Roche AMPLICOR human immunodeficiency virus type 1 [HIV-1] Monitor, Chiron enhanced-sensitivity bDNA, and Organon Teknika NASBA HIV-1 QT) and two in-house assays (from National Genetics Institute and Baylor College of Medicine) were compared with a blinded panel. The results were evaluated as to intra-assay sensitivity, precision, and ability to detect differences in a dilution series.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9508327      PMCID： PMC104640          DOI： 10.1128/JCM.36.3.835-839.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  HIV viral load markers in clinical practice.

Authors:  M S Saag; M Holodniy; D R Kuritzkes; W A O'Brien; R Coombs; M E Poscher; D M Jacobsen; G M Shaw; D D Richman; P A Volberding
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

2.  Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  H Revets; D Marissens; S de Wit; P Lacor; N Clumeck; S Lauwers; G Zissis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.

Authors:  B Yen-Lieberman; D Brambilla; B Jackson; J Bremer; R Coombs; M Cronin; S Herman; D Katzenstein; S Leung; H J Lin; P Palumbo; S Rasheed; J Todd; M Vahey; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.

Authors:  A J Conrad; P Schmid; K Syndulko; E J Singer; R M Nagra; J J Russell; W W Tourtellotte
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-12-01

5.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

6.  An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  D Kern; M Collins; T Fultz; J Detmer; S Hamren; J J Peterkin; P Sheridan; M Urdea; R White; T Yeghiazarian; J Todd
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  R Schuurman; D Descamps; G J Weverling; S Kaye; J Tijnagel; I Williams; R van Leeuwen; R Tedder; C A Boucher; F Brun-Vezinet; C Loveday
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  J Coste; B Montes; J Reynes; M Peeters; C Segarra; J P Vendrell; E Delaporte; M Segondy
Journal:  J Med Virol       Date:  1996-12       Impact factor: 2.327

9.  Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection.

Authors:  B van Gemen; T Kievits; R Schukkink; D van Strijp; L T Malek; R Sooknanan; H G Huisman; P Lens
Journal:  J Virol Methods       Date:  1993-07       Impact factor: 2.014

10.  Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA.

Authors:  H J Lin; L E Myers; B Yen-Lieberman; F B Hollinger; D Henrard; C J Hooper; R Kokka; S Kwok; S Rasheed; M Vahey
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226
View more
  11 in total

1.  Comparative evaluation of two branched-DNA human immunodeficiency virus type 1 RNA quantification assays with lower detection limits of 50 and 500 copies per milliliter.

Authors:  C Manegold; C Krempe; H Jablonowski; L Kajala; M Dietrich; O Adams
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples.

Authors:  A Aguilera; A Vela; M Treviño; E Varela; R Seoane; B J Regueiro
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients.

Authors:  Dwight R Stickney; Zoja Noveljic; Armando Garsd; Daniel A Destiche; James M Frincke
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

4.  The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.

Authors:  Aleksandr Lazaryan; Wei Song; Elena Lobashevsky; Jianming Tang; Sadeep Shrestha; Kui Zhang; Janet M McNicholl; Lytt I Gardner; Craig M Wilson; Robert S Klein; Anne Rompalo; Kenneth Mayer; Jack Sobel; Richard A Kaslow
Journal:  Hum Immunol       Date:  2011-01-21       Impact factor: 2.850

5.  Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study.

Authors:  M J Nowicki; L Benning; J W Bremer; W A Meyer; C Hanson; D Brambilla; S Silver; A Kovacs
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 6.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.

Authors:  T Elbeik; E Charlebois; P Nassos; J Kahn; F M Hecht; D Yajko; V Ng; K Hadley
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Monitoring the quality of HIV-1 viral load testing through a proficiency testing program using dried tube specimens in resource-limited settings.

Authors:  Shon Nguyen; Artur Ramos; Joy Chang; Bin Li; Vedapuri Shanmugam; Debrah Boeras; John N Nkengasong; Chunfu Yang; Dennis Ellenberger
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

9.  Reproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  D G Murphy; P Gonin; M Fauvel
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 10.  Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.

Authors:  Yi-Wei Tang; Chin-Yih Ou
Journal:  Emerg Microbes Infect       Date:  2012-08-22       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.